These include: He points out that the choice to undergo cataract surgery often arises when these visual problems start to seriously impact your everyday life and glasses or contact lenses no longer ...

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

Both collaborations aim to enhance education, clinical care and research in ophthalmology. Read more at straitstimes.com.